Hepatitis C- updates on biology and new treatments from Prof. Josh Davis

Guest posting: A/Prof Josh Davis, Infectious Diseases Physician, John Hunter Hospital,  NSW, Principal  Research Fellow, Menzies School of Health Research, NT, Australia.


The HCV treatment landscape is rapidly changing!

  • Key unresolved questions include:
    • How to upscale roll out to GPs
    • How much monitoring is needed with DAAs
    • How to treat “special populations”:
      • Renal disease
      • Children
      • Decompensated cirrhosis
      • Pregnancy
  • ?Role of DAAs in PEP and prevention of MTCT

Image credit: http://www2.hawaii.edu/~dewolfe/virus.html

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: